ENSYSCE BIOSCIENCES, INC. Value of Shares Repurchased
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Value of Shares Repurchased of $937.50 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Shareholders' Equity
us-gaap:StockRepurchasedDuringPeriodValue · last filed 2018-11-07
- 2017-09-30: Stock Repurchased During Period, Value 9 month $937.50K.
| Period end | Stock Repurchased During Period, Value 9 month |
|---|---|
| 2017-09-30 | $937.50K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |